SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Frank Greiffenstein who wrote (530)3/12/1998 5:45:00 PM
From: Bradpalm1  Read Replies (1) of 34592
 
Frank,

I agree with you. While EXTI may be a worthwhile short-term play based on positive funding news, the long-term and widespread potential of this technology is much more unclear. The use of liver dialysis may be suitable for patients awaiting liver transplantation or for transient support for reversible hepatic failure, but it's unrealistic to think that every hospital will spring for such a device or 'hepatic dialysis centers' will be springing up on every street corner. This technology will probably be ultimately limited only to major tertiary medical centers who have the resources to wisely and selectively utilize it.

Bradpalm1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News